exRNAdisease

Entry Detail

---



General Information

Database ID: exR0201491 RNA Name: hsa-miR-155-5p RNA Type: miRNA Chromosome: chr21 Starnd: + Coordinate: Start Site(bp): 25573983 End Site(bp): 25574006 External Links: hsa-miR-155-5p

Disease Information

Disease Name: Mild Cognitive Impairment Disease Category: Other Diseases MeSH ID: D060825 Type: Psychiatry and Psychology Category/Mental Disorders Alias: Cognitive Dysfunction//Cognitive Dysfunctions//Dysfunction, Cognitive//Dysfunctions, Cognitive//Cognitive Impairments//Cognitive Impairment//Impairment, Cognitive//Impairments, Cognitive//Mild Cognitive Impairment//Cognitive Impairment, Mild//Cognitive Impairments, Mild//Impairment, Mild Cognitive//Impairments, Mild Cognitive//Mild Cognitive Impairments//Mild Neurocognitive Disorder//Disorder, Mild Neurocognitive//Disorders, Mild Neurocognitive//Mild Neurocognitive Disorders//Neurocognitive Disorder, Mild//Neurocognitive Disorders, Mild//Cognitive Decline//Cognitive Declines//Decline, Cognitive//Declines, Cognitive//Mental Deterioration//Deterioration, Mental//Deteriorations, Mental//Mental Deteriorations

Expression Detail

GEO ID: GSE120584 Description: Risk prediction models for dementia constructed by supervised principal component analysis using miRNA expression data Experimental Design: Disease vs Control Case Disease Type: Alzheimer's Disease Case Disease SubType: NA Case Sample: Mild Cognitive Impairment Control Sample: Normal Number of Case: 1021 Number of Control: 288 Number of Samples: 1309

Regulatory Relationship

mRNA targets: Gene Symbol Chromosome Start Site(bp) End Site(bp) Strand TSC22D4 chr7 100463359 100479232 - ACOT7 chr1 6264269 6394391 - MRFAP1 chr4 6640091 6642745 + SH3KBP1 chrX 19533977 19887600 - NUFIP2 chr17 29255839 29294148 - CENPM chr22 41938737 41947152 - SP100 chr2 230415942 230545606 + ARL3 chr10 102673731 102714397 - JAK1 chr1 64833229 65067754 - LAPTM4A chr2 20032650 20051628 - SOD2 chr6 159669069 159745186 - HNRNPLL chr2 38561969 38603586 - LCP1 chr13 46125920 46211871 - AICDA chr12 8602170 8612867 - CD52 chr1 26317958 26320523 + MFSD9 chr2 102714630 102736888 - NDUFA4 chr7 10931943 10940153 - CHEK2 chr22 28687743 28742422 - ZMYM5 chr13 19823482 19863649 - PGLS chr19 17511636 17521288 + CCNB1 chr5 69167135 69178245 + IL2RG chrX 71107404 71112108 - CXXC1 chr18 50282343 50288304 - RBM38 chr20 57391396 57409333 + CFL1 chr11 65823022 65862026 - PPM1B chr2 44167969 44244384 + ZFP36 chr19 39406847 39409412 + FTL chr19 48965309 48966879 + ERH chr14 69380128 69398299 - VPS18 chr15 40894450 40903975 + miRNA targets: NA circRNA targets: circRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand hsa_circ_0000642 chr15 80390757 80415142 + hsa_circ_0000892 chr19 11941431 12014514 + hsa_circ_0001046 chr2 97024782 97033111 + hsa_circ_0000643 chr15 80412669 80415142 + hsa_circ_0000698 chr16 47531309 47549512 + hsa_circ_0001146 chr20 34241449 34246936 - lncRNA targets: lncRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand AC021078.1 chr5 149494314 149504670 - AC090198.1 chr8 124488510 124491643 + AC245033.4 chr15 82533175 82540008 - AL022311.1 chr22 37876148 37895563 + ELOA-AS1 chr1 23706901 23778296 - GABPB1-AS1 chr15 50354959 50372202 + LINC00240 chr6 26956932 27059749 + LINC01772 chr1 16460948 16468481 + MALAT1 chr11 65497688 65506516 + MIR155HG chr21 25561909 25575168 + MIR17HG chr13 91347820 91354579 + NORAD chr20 36045618 36051018 - OIP5-AS1 chr15 41283990 41309737 + SNHG5 chr6 85650491 85678932 - XIST chrX 73820649 73852723 - Display:

Experiment Detail

GEO ID: GSE120584 Sample Source: Blood Source Fraction: Serum Platform: GPL21263 Method: Microarray Num of detected RNA Type: 1 Num of detected RNAs of this Type: 2532 Sample treatment protocol: NA RNA Extract protocol: Total RNA was extracted each from 300uL serum samples using 3D-Gene® RNA extraction reagent from liquid sample kit (Toray Industries, Inc.). RNA library preparation protocol: miRNA was labeled using 3D-Gene® miRNA Labeling kit in accordance with the manufacturer's instructions.

Reference

PMID: 30820472 Title: Risk prediction models for dementia constructed by supervised principal component analysis using miRNA expression data Author: Shigemizu D, Akiyama S, Asanomi Y, Boroevich KA, Sharma A, Tsunoda T, Matsukuma K, Ichikawa M, Sudo H, Takizawa S, Sakurai T, Ozaki K, Ochiya T, Niida S Journal: Commun Biol. 2019 Feb 25;2:77. Description: we investigated potential miRNA biomarkers and constructed risk prediction models, based on a supervised principal component analysis (PCA) logistic regression method, according to the subtype of dementia